Skip to main content
Search results
https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-combination-pertuzumab-trastuzumab-and-hyaluronidase-zzxf-her2-positive-breast-cancer
FDA approves combination of pertuzumab, trastuzumab, and hyaluronidase-zzxf...a new fixed-dose combination of pertuzumab, trastuzumab, and ...
https://www.fda.gov/media/171345/download
Breast Cancer - Tissue Perjeta (pertuzumab) BLA 125409 ERBB2 (HER2) ERBB2 (HER2)...Breast Cancer - Tissue Perjeta (pertuzumab) BLA 125409 ERBB2 (HER2) ...
https://www.fda.gov/media/173980/download
Trade Name: PERJETA Proper Name: PERTUZUMAB Total Drug Content (Concentration)...Trade Name: PHESGO Proper Name: PERTUZUMAB, TRASTUZUMAB, AND ...
https://www.fda.gov/media/89589/download
...pembrolizumab Keytruda 09/04/14 125409 pertuzumab Perjeta 06/08/12 06/08/12 06/08/24
https://www.fda.gov/medical-devices/in-vitro-diagnostics/list-cleared-or-approved-companion-diagnostic-devices-in-vitro-and-imaging-tools
Breast Cancer - Tissue Perjeta (pertuzumab) BLA 125409 ERBB2 (HER2) ERBB2 (HER2)...Breast Cancer - Tissue Perjeta (pertuzumab) BLA 125409 ERBB2 (HER2) ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-enhertu-fam-trastuzumab-deruxtecan-nxki-adult-patients
...receptor status, prior treatment with pertuzumab, and history of visceral disease
https://www.fda.gov/consumers/owh-funded-research/project-areas-topic
...induced by trastuzumab, trastuzumab/pertuzumab, and ado-trastuzumab emtansine to...induced by trastuzumab, trastuzumab/pertuzumab, and ado-trastuzumab ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-regular-approval-fam-trastuzumab-deruxtecan-nxki-breast-cancer
...receptor status, prior treatment with pertuzumab, and history of visceral disease
https://www.fda.gov/media/105605/download
...pembrolizumab Keytruda 09/04/14 125409 pertuzumab Perjeta 06/08/12 06/08/12 06/08/24
https://www.fda.gov/media/162006/download
...ibalizumab DN41 - ustekinumab DN42 - pertuzumab DN43 - denosumab DN45 - obinutuzumab...daratumumab and hyaluronidase DN79 - pertuzumab, trastuzumab ...
https://www.fda.gov/news-events/press-announcements/la-fda-aprueba-tratamiento-para-el-cancer-de-seno-que-puede-ser-administrado-en-casa-por-un
...aprobó Phesgo, una combinación de pertuzumab, trastuzumab y hialuronidasa–zzxf...crecimiento de las células cancerosas. Pertuzumab y trastuzumab se ...
https://www.fda.gov/news-events/press-announcements/fda-approves-breast-cancer-treatment-can-be-administered-home-health-care-professional
...approved Phesgo—a combination of pertuzumab, trastuzumab and hyaluronidase–zzxf—for...promotes the growth of cancer cells. Pertuzumab and trastuzumab ...
https://www.fda.gov/drugs/resources-information-approved-drugs/oncology-cancer-hematologic-malignancies-approval-notifications
...6/29/2020 FDA approves combination of pertuzumab, trastuzumab, and hyaluronidase-zzxf...a new fixed-dose combination of pertuzumab, trastuzumab, and ...
https://www.fda.gov/drugs/resources-information-approved-drugs/verified-clinical-benefit-cancer-accelerated-approvals
...test 1/8/2014 11/20/2015 Perjeta (pertuzumab) In combination with trastuzumab
https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling
Precautions, Clinical Pharmacology Pertuzumab (1) Oncology ERBB2 (HER2) Indications...Clinical Pharmacology, Clinical Studies Pertuzumab (2) Oncology ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-regular-approval-pertuzumab-adjuvant-treatment-her2-positive-breast-cancer
FDA grants regular approval to pertuzumab for adjuvant treatment of HER2-positive...Administration granted regular approval to pertuzumab (PERJETA ...
https://www.fda.gov/media/143991/download
Nyvepria (pegfilgrastim-apgf) - Phesgo (pertuzumab, trastuzumab + hyaluronidase-zzxf)
https://www.fda.gov/media/104555/download
...125409 Genentech, Inc. Perjeta (pertuzumab) 6/8/12 0 to 16 yrs Necessary studies...125409/S-051 Genentech, Inc. Perjeta (pertuzumab) 9/30/13 0 to 16 ...
https://www.fda.gov/media/171478/download
Trade Name: PERJETA Proper Name: PERTUZUMAB August 2023 Page 50 of 105 *****...Trade Name: PHESGO Proper Name: PERTUZUMAB, TRASTUZUMAB, AND ...
https://www.fda.gov/media/147397/download
COMPANY S 6/15/2020 BLA 761170 PHESGO PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF